Rocket Pharmaceuticals (RCKT) Interest & Investment Income (2015 - 2026)
Rocket Pharmaceuticals (RCKT) reported Interest & Investment Income of $161000.0 for Q1 2026, down 87.95% on a YoY basis from $1.3 million in Q1 2025, and down 76.67% sequentially from $690000.0 in Q4 2025.
Rocket Pharmaceuticals (RCKT) Interest & Investment Income (2015 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 12 years of Interest & Investment Income data on file, last reported at $161000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 87.95% year-over-year to $161000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 68.92% YoY), and the FY2025 full-year result was $3.2 million, down 61.07% from the prior year.
- Interest & Investment Income fell to $161000.0 in Q1 2026, from $690000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q1 2024 to a low of $161000.0 in Q1 2026.
- A 5-year average of $1.2 million and a median of $1.2 million in 2022 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 11250.0% in 2022 and plunged 87.95% in 2026, its largest moves.
- Tracing RCKT's Interest & Investment Income over 5 years: stood at $1.2 million in 2022, then slumped by 34.62% to $814000.0 in 2023, then surged by 98.65% to $1.6 million in 2024, then plunged by 57.33% to $690000.0 in 2025, then sank by 76.67% to $161000.0 in 2026.
- Business Quant data shows RCKT's Interest & Investment Income at $161000.0 in Q1 2026, $690000.0 in Q4 2025, and $709000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Rocket Pharmaceuticals | 359.39 Mn | 359.39 Mn | - | 161,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 709,000.00 |
| Jun 30, 2025 | 483,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 814,000.00 |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 669,000.00 |
| Mar 31, 2022 | 623,000.00 |
| Dec 31, 2021 | 850,000.00 |
| Sep 30, 2021 | 806,000.00 |
| Jun 30, 2021 | -6,000.00 |